HAROLD SCOTT: Open Payments
NPI 1396719688 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $171 · 2025 $425
Food & beverage: $357Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $116 |
| BIOPROTECT MEDICAL, INC. | 4 | $99 |
| Sumitomo Pharma America, Inc. | 5 | $79 |
| Ferring Pharmaceuticals Inc. | 2 | $32 |
| Laborie Medical Technologies Corp. | 1 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| AVYXA PHARMA, LLC | 1 | $18 |
| 180 Medical, Inc. | 1 | $17 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
Products named: ERLEADA, BIOPROTECT BALLOON IMPLANT SYSTEM, GEMTESA, ADSTILADRIN, Optilume BPH Drug Coated Balloon Catheter, AZMIRO, LUTRATE DEPOT, Trelstar.
Industry payments across NJ — which companies pay providers there.
